ClinicalTrials.Veeva

Menu

Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes

S

Steno Diabetes Centers

Status

Completed

Conditions

Hypoglycemia
Breastfeeding

Treatments

Device: Continuous glucose monitoring (CGM)

Study type

Observational

Funder types

Other

Identifiers

NCT02898428
SDC-2016-055

Details and patient eligibility

About

With appropriate day-time carbohydrate intake and insulin dose, the 24 hour glucose levels and prevalence of night-time hypoglycaemia are comparable in breastfeeding new mothers and formula feeding new mothers with type 1 diabetes at the second after delivery diabetes control compared with the first after delivery diabetes control at Steno Diabetes Center.

Enrollment

65 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 45 years.
  • Delivery of a single infant.
  • Proficiency in Danish to read and understand the patient information sheet, questionnaires and to converse with the diabetes caregivers.

Exclusion criteria

  • A diagnosis with severe mental or psychiatric barriers or a concurrent disease on the decision of the principal investigator

Trial design

65 participants in 2 patient groups

New mothers
Description:
New mothers with type 1 diabetes
Treatment:
Device: Continuous glucose monitoring (CGM)
Control group
Description:
Non-pregnant, non-breastfeeding women with type 1 diabetes matched for age and BMI
Treatment:
Device: Continuous glucose monitoring (CGM)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems